Please wait

 

Exhibit 8

 

Dr. Reddy’s Laboratories Limited

 

Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries, associates and joint ventures as of March 31, 2020:

 

Name of the subsidiary/joint venture   Country of
Incorporation		   Percentage of Direct/Indirect
Ownership Interest
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd.   Malaysia   100%(3)
Aurigene Discovery Technologies Inc.   U.S.A.   100%(3)
Aurigene Discovery Technologies Limited   India   100%
Aurigene Pharmaceutical Services Limited (from September 16, 2019)   India   100%(3)
beta Institut gemeinnützige GmbH   Germany   100%(8)
betapharm Arzneimittel GmbH   Germany   100%(8)
Cheminor Investments Limited   India   100%
Cheminor Employees Welfare Trust   India   Refer to below footnote(16)
Chirotech Technology Limited   United Kingdom   100%(2)(5)
Dr. Reddy’s Research Foundation   India   Refer to below footnote(16)
Dr. Reddy's Employees ESOS Trust (from July 27, 2018)   India   Refer to below footnote(16)
Dr. Reddy’s Farmaceutica Do Brasil Ltda.   Brazil   100%
Dr. Reddy’s Laboratories (EU) Limited   United Kingdom   100%(10)
Dr. Reddy’s Laboratories (Proprietary) Limited   South Africa   100%(10)
Dr. Reddy’s Laboratories (UK) Limited   United Kingdom   100%(5)
Dr. Reddy’s Laboratories Canada, Inc.   Canada   100%(10)
Dr. Reddy's Laboratories Chile SPA.   Chile   100%(10)
Dr. Reddy’s Laboratories Inc.   U.S.A.   100%(10)
Dr. Reddy’s Laboratories Japan KK   Japan   100%(10)
Dr. Reddy’s Laboratories Kazakhstan LLP   Kazakhstan   100%(10)
Dr. Reddy’s Laboratories Louisiana LLC   U.S.A.   100%(6)
Dr. Reddy’s Laboratories Malaysia Sdn. Bhd.   Malaysia   100%(10)
Dr. Reddy’s Laboratories New York, Inc.   U.S.A.   100%(10)
Dr. Reddy's Laboratories Philippines Inc. (from May 9, 2018)   Philippines   100%(10)
Dr. Reddy’s Laboratories Romania S.R.L.   Romania   100%(10)
Dr. Reddy’s Laboratories SA   Switzerland   100%
Dr. Reddy's Laboratories Taiwan Limited   Taiwan   100%(10)
Dr. Reddy's Laboratories (Thailand) Limited (from June 13, 2018)   Thailand   100%(10)
Dr. Reddy’s Laboratories, LLC   Ukraine   100%(10)
Dr. Reddy’s New Zealand Limited.   New Zealand   100%(10)
Dr. Reddy’s S.R.L   Italy   100%(11)
Dr. Reddy's Bio-Sciences Limited   India   100%
Dr. Reddy's Laboratories (Australia) Pty. Limited   Australia   100%(10)
Dr. Reddy's Laboratories SAS   Colombia   100%(10)
Dr. Reddy's Research and Development B.V. (formerly Octoplus B.V.)   Netherlands   100%(12)
Dr. Reddy's Venezuela, C.A.   Venezuela   100%(10)
Dr. Reddy’s (WUXI) Pharmaceutical Company Limited   China   100%(10)
DRANU LLC   U.S.A.   50%(2)(13)
DRES Energy Private Limited   India   26%(14)
DRL Impex Limited   India   100%(15)
Dr. Reddy's Laboratories B.V. (formerly Eurobridge Consulting B.V.)   Netherlands   100%(1)
Idea2Enterprises (India) Pvt. Limited   India   100%
Imperial Credit Private Limited   India   100%
Industrias Quimicas Falcon de Mexico, S.A. de CV   Mexico   100%
Kunshan Rotam Reddy Pharmaceutical Company Limited   China   51.33%(4)
Lacock Holdings Limited   Cyprus   100%(10)
OOO Dr. Reddy's Laboratories Limited   Russia   100%(10)
OOO DRS LLC   Russia   100%(9)
Promius Pharma LLC   U.S.A.   100%(6)
Reddy Holding GmbH   Germany   100%(10)
Reddy Netherlands B.V.   Netherlands   100%(10)
Reddy Pharma Iberia SAU   Spain   100%(10)
Reddy Pharma Italia S.R.L.   Italy   100%(7)
Reddy Pharma SAS   France   100%(10)
Regkinetics Services Limited (formerly Dr. Reddy’s Pharma SEZ Limited)   India   100%

 

 

 

 

(1)Indirectly owned through Reddy Netherlands B.V. (from March 28, 2019), formerly a subsidiary of Dr. Reddy’s Research and Development B.V.
(2)Entities under liquidation.
(3)Indirectly owned through Aurigene Discovery Technologies Limited.
(4)Kunshan Rotam Reddy Pharmaceutical Company Limited is a subsidiary as per Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment by the equity method and does not consolidate it in the Company’s financial statements.
(5)Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited.
(6)Indirectly owned through Dr. Reddy’s Laboratories Inc.
(7)Indirectly owned through Lacock Holdings Limited.
(8)Indirectly owned through Reddy Holding GmbH.
(9)Indirectly owned through OOO Dr. Reddy's Laboratories Limited.
(10)Indirectly owned through Dr. Reddy’s Laboratories SA.
(11)Indirectly owned through Reddy Pharma Italia S.R.L.
(12)Indirectly owned through Reddy Netherlands B.V.
(13)DRANU LLC is consolidated in accordance with guidance available in IFRS 10.
(14)Accounted in accordance with IFRS 11, “Joint Arrangements”.
(15)Indirectly owned through Idea2Enterprises (India) Private Limited.
(16)The Company does not have any equity interests in this entity, but has significant influence or control over it.